0
Nov 16 (Reuters) – Rein Therapeutics Inc: * REIN THERAPEUTICS ANNOUNCES PRELIMINARY BLINDED PHASE 2 RENEW DATA SHOWING ENCOURAGING LUNG FUNCTION TRENDS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)